Astrazeneca pushes FTSE past 5,600 mark

clock •

The FTSE 100 has topped 5,600 for the first time since August 2001. The index is currently up 3.9 points, or 0.07%, to 5,600.9, led higher by drugmaker AstraZeneca after it said it was buying a cancer specialist firm to boost its drug pipeline.

Drugmaker AstraZeneca has added 17p, or 0.61%, to 2,795p, as the firm said it had agreed to buy privately owned UK biotechnology company KuDOS Pharmaceuticals for $210m in cash in its latest move to bolster its pipeline of new drugs. Elsewhere, defence group BAE Systems has slipped 1p, or 0.26%, to 324p, despite recent news of a deal between Britain and Saudi Arabia to supply the world's top oil producer with new fighter jets. Miners are supporting the market, with Xstrata gaining 7p, or 0.52%, to 1,345p, after gold prices firmed above $500 an ounce and Shanghai copper futures traded ...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Watch Professional Adviser's Working Lunch with Baillie Gifford - Emerging Future: Rethinking the World's Growth Engine

Watch Professional Adviser's Working Lunch with Baillie Gifford - Emerging Future: Rethinking the World's Growth Engine

Catch up on the discussion

Professional Adviser
clock 13 October 2026 • 1 min read
Fifty years after 'Bogle's Folly', what comes next for financial advice?

Fifty years after 'Bogle's Folly', what comes next for financial advice?

'Indexing will continue to grow, but the wrapper through which investors access it will change'

Gillian Hepburn
clock 12 October 2026 • 4 min read
Chris Justham: Why the industry must 'entertain and engage' investors

Chris Justham: Why the industry must 'entertain and engage' investors

‘We can’t just offer them a dry cracker and ask them to chew it down’

Chris Justham
clock 07 October 2026 • 3 min read